Business Wire

Wolters Kluwer Launches AI-enhanced UpToDate Enterprise Edition in EMEA

4.6.2025 16:30:00 EEST | Business Wire | Press release

Share

Wolters Kluwer Health today announced its UpToDate® Enterprise Edition will be available to healthcare systems and hospitals in the Europe, Middle East, and Africa (EMEA) region beginning in Q3. Designed specifically for large healthcare systems and hospitals, the clinical decision support (CDS) solution, which features AI enhancements, is designed to support healthcare administrators and clinicians to help deliver consistently high-quality care. Wolters Kluwer Health will demonstrate the solution at HIMSS25 Europe in Paris, June 10-12, 2025.

“Leveraging AI technology, UpToDate Enterprise Edition goes beyond traditional decision support to provide unparalleled quality that supports streamlined, integrated workflows and faster time-to-answers, ultimately fostering patient engagement and transforming care delivery,” said Christian Cella, Vice President, International Segment for Clinical Effectiveness at Wolters Kluwer Health. “With UpToDate Enterprise becoming available in EMEA, we are extending Wolters Kluwer’s commitment to enhancing clinical decision-making worldwide.”

For decades, healthcare professionals around the world have trusted UpToDate clinical decision support to enable confident decision-making and reduce variability in care. The UpToDate Enterprise Edition solution builds on that value to include advanced features, insights, and technology innovations to help them meet these current and emerging industry challenges. The solution is in early release at 40 of the largest health systems in EMEA joining the over 350 health systems in North America using the UpToDate Enterprise Edition.

“UpToDate has been an extremely valuable clinical decision support resource for Icelandic health institutions. UpToDate Enterprise Edition adds new features including AI that will aid our staff to make smarter clinical decisions to further help improve patient care,” says Runólfur Pálsson, CEO of Landspítali University Hospital and Professor of Medicine at the Faculty of Medicine of the University of Iceland.

UpToDate Enterprise Edition offers harmonized content and solutions for the entire care team, empowering them to make more informed, confident, and impactful decisions. With its AI-Enhanced Search capabilities, clinicians can now experience the efficiency of receiving highly focused verbatim answers from a market leading clinical decision solution using natural language queries—a time-saver for busy healthcare professionals. The AI-powered Analytics Dashboard offers healthcare organizations the ability to harness valuable organizational data for improved efficiency and educational opportunities.

“Deploying UpToDate Enterprise Edition is an important initiative in supporting our digital innovation strategy,” said Professor Adrian Harris, Chief Medical Officer at the Royal Devon University Healthcare NHS Foundation Trust. “By leveraging the data, analytics and AI capabilities now available within UpToDate, we can further support medical education and optimize clinical decision making, helping us deliver the best possible care for all patients and enabling our local population to stay well.”

This enhanced solution unifies care teams and administrators with a focus on workflow innovation, analytics, and advanced care features. With access across teams, organizations can:

  • Manage complexity by advancing clinical decisions
  • Enhance satisfaction and collaboration by aligning all members of the care team to the same trusted UpToDate content with advanced decision-making features
  • Help alleviate burnout through improved workflow capabilities
  • Improve resource utilization and business outcomes via system-wide data and insights and self-service analytics, such as system-wide topic usage, UpToDate topic benchmarking, and CME accreditation activity.

In the Frost Radar™: Clinical Decision Support System, 2025report, Wolters Kluwer was the only one named both a “Company to Action” and the market leader for innovation. Frost & Sullivan screened and analyzed more than 60 clinical decision support vendors across point-of-care segments and short-listed 10 companies based on a detailed analysis of their corporate growth potential and ability to drive visionary innovation in this space.

Learn more about UpToDate Enterprise Edition in EMEA.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250604785080/en/

Contacts

Media Contact
Suzanne Moran
Associate Director, External Communications
Health
Wolters Kluwer
Office/Mobile: +1 6178938586
Suzanne.Moran@Wolterskluwer.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Special Olympics Airlift Takes Flight Nationwide; Dove 1 Arrives at St. Paul Downtown Airport19.6.2026 18:09:00 EEST | Press release

The 2026 Special Olympics Airlift officially took flight today as all participating Cessna, Beechcraft and Hawker aircraft, known as Doves, departed from airports across the country. Dove 1 for arrival day, a Cessna Citation Latitude generously operated by Prent Corporation, landed at St. Paul Downtown Airport (STP) carrying Special Olympic athletes and delegation members, signaling the start of Airlift arrivals for the Special Olympics USA Games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619085293/en/ Special Olympics Airlift takes flight nationwide; Dove 1 arrives at St. Paul Downtown Airport (Photo credit: Textron Aviation). The arrival signals the start of the world’s largest cumulative peacetime airlift spanning more than 40 years, a coordinated aviation effort organized by Textron Aviation, a Textron Inc. (NYSE: TXT) company, that transports hundreds of Special Olympics athletes and coaches from multiple states

Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction19.6.2026 17:53:00 EEST | Press release

Record Currency Management Ltd (RCM), subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce its participation in an innovative local currency bond transaction issued by the European Bank for Reconstruction and Development (EBRD), supporting the development of Mongolia's capital markets while providing institutional investors with access to attractive frontier market opportunities. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group managing USD 115 billion of assets on behalf of institutional clients worldwide. Record's client base comprises pension funds, foundations, sovereign institutions and other asset managers, with whom the Group has built long-standing relationships through its focus on bespoke investment and risk management solutions. Headquartered in London, Record has offices in Hamburg, Zurich, Zug, New York, and Hong Kong. The investment forms part of Record Financial Group's broad

Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 15:29:00 EEST | Press release

Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level

Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye